Profil bibliographique

Francesco Iachetta

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

50Publications signalées

664Citations signalées

2Affiliations récentes

Institutions déclarées

Azienda Sanitaria Unità Locale di Reggio Emilia Istituti di Ricovero e Cura a Carattere Scientifico

Domaines associés

Colorectal Cancer Treatments and StudiesGastric Cancer Management and OutcomesCancer Immunotherapy and BiomarkersColorectal Cancer Surgical TreatmentsColorectal Cancer Screening and Detection

Publications récentes

2026 conference-abstractOpenAlex

Durvalumab plus platinum-etoposide in extensive-stage extrapulmonary small cell carcinoma (ES-EPSCC): Second safety assessment of the DURVASCC trial (GOIRC-01-2021).

Giuseppe Maglietta, Angela Damato, Francesca Spada, Francesco Iachetta et autres

0 citationsJournal of Clinical Oncology

2026 conference-abstractOpenAlex

Estimating survival in advanced cancer: A prospective single-center study on the accuracy of oncologists’ prognostic accuracy (Pre-Sur).

Giulia Claire Giudice, Giamaica Ciardello, Erika Gervasi, Francesca Zanelli et autres

0 citationsJournal of Clinical Oncology

Accès ouvert 2026 articleOpenAlex

First-line Nivolumab plus FOLFOXIRI/Bevacizumab in advanced RAS/BRAF-mutated colorectal cancer: efficacy, safety and biomarker discovery from the phase II NIVACOR trial

Angela Damato, Riziero Esposito Abate, S. Tessitore, Daniela Frezzetti et autres

2 citationsNature Communications

2026 conference-abstractOpenAlex

Italian prospective observational RealFLOT study: Four-year update.

Irene Valle, Elisa Giommoni, Daniele Lavacchi, Daniele Rossini et autres

1 citationJournal of Clinical Oncology

Accès ouvert 2025 articleOpenAlex

Agnostic phase II, multicenter, single-arm study with DURVAlumab plus carboplatin or cisplatin and etoposide as first-line treatment in extensive stage - Extrapulmonary Small Cell Carcinoma (EPSCC) patients – DURVASCC trial (GOIRC-01-2021)

Angela Damato, Giuseppe Maglietta, Lorenzo Antonuzzo, Rossana Berardi et autres

0 citationsBMC Cancer

2025 articleOpenAlex

3183eP Pre-Sur: An observational, prospective and monocentric study to evaluate oncologists' accuracy in clinical prediction of survival in patients with advanced cancer

Giulia Claire Giudice, Giamaica Ciardiello, Erika Gervasi, Francesca Zanelli et autres

0 citationsAnnals of Oncology

2024 conference-abstractOpenAlex

Immune response to SARS-CoV-2 vaccine administered to patients with solid cancers under systemic treatment: A prospective, monocentric study (Immunocovid-19).

Francesco Caputo, Martina Rotolo, Edoardo Carretto, Laura Albertazzi et autres

0 citationsJournal of Clinical Oncology

2024 conference-abstractOpenAlex

Correlation between metastatic site and immunotherapy efficacy in patients with advanced dMMR/MSI colorectal cancer: Real-World Italian multicentric retrospective study (Colon-MSI).

Francesco Iachetta, Chiara Cremolini, Giamaica Ciardiello, Angela Damato et autres

1 citationJournal of Clinical Oncology

2024 conference-abstractOpenAlex

Phase II randomized study of maintenance therapy with regorafenib (REGO) versus placebo after first-line platinum and fluoropyrimidines-based chemotherapy in HER2 negative locally advanced/metastatic gastric (GC) or gastroesophageal junction (GEJ) cancer: Results of a-MANTRA study (GOIRC-05-2016).

Angela Damato, Domenico Bilancia, Francesco Iachetta, Antonia Strippoli et autres

1 citationJournal of Clinical Oncology

2024 articleOpenAlex

109P Prognostic genomic signatures in RAS/BRAF mutant (mut) metastatic colorectal cancer (mCRC) patients (pts) from the phase II study of NIVolumab (niv) plus FOLFOXIRI/Bevacizumab (bev) in first-line therapy of Advanced COloRectal cancer (NIVACOR- GOIRC-03-2018)

Nicola Normanno, Angela Damato, Riziero Esposito Abate, S. Tessitore et autres

0 citationsAnnals of Oncology

Accès ouvert 2024 articleOpenAlex

421P Maintenance therapy with regorafenib (REGO) versus placebo after first-line (1L) platinum and fluoropyrimidines-based chemotherapy in HER2-negative advanced gastric (GC)/gastroesophageal junction (GEJ) cancer: Results of phase II randomized a-MANTRA study (GOIRC-05-2016)

A. Damato, D. Bilancia, Francesco Iachetta, Antonia Strippoli et autres

1 citationAnnals of Oncology

2023 conference-abstractOpenAlex

Efficacy of immunotherapy in MSI metastatic colorectal cancer patients: A Real-World Italian multicentric retrospective study (Colon-MSI Study).

Francesco Iachetta, Chiara Cremolini, Francesco Caputo, Giamaica Ciardiello et autres

1 citationJournal of Clinical Oncology

Profil ORCID Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, ROR et la Banque mondiale, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune donnée externe enregistrée en base. Sources et limites.